Clinical Trial


A Safety Extension Study of Ontamalimab in Participants With Moderate to Severe Ulcerative Colitis or Crohn's Disease (AIDA)


Brief description

The purpose of this study is to evaluate the safety and tolerability of long-term treatment with ontamalimab in participants with moderate to severe Ulcerative Colitis (UC) or Crohn's disease (CD).

Keywords

  •   Crohn's Disease
  •   Ulcerative Colitis

Sponsored By

Shire

Unique Study ID

NCT03283085

Investigators and Research Sites Near You - Found( 3 )

No Investigator Listed

R-Pharm
85210, Mesa, Arizona, United States
Distance from Current Trial is 0 miles

No Investigator Listed

Bayer
85210, Mesa, Arizona, United States
Distance from Current Trial is 0 miles

No Investigator Listed

Bayer
85209, Mesa, Arizona, United States
Distance from Current Trial is 0 miles
View All